Search results
SHINGRIX is a two-dose shingles vaccine that has been available across Canada since the beginning of 2018. SHINGRIX was shown to be over 90% effective at preventing shingles for people 50 years of age and older in clinical trials.
SHINGRIX is a two-dose vaccine for the prevention of shingles that has been available across Canada since the beginning of 2018. SHINGRIX was shown to be over 90% effective at preventing shingles for people 50 years of age and older in clinical trials involving more than 29,000 people.
SHINGRIX is a vaccine that helps to protect adults against shingles (herpes zoster). SHINGRIX can be given to adults 50 years of age and older, and adults 18 years and older who are or will be at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy. 100% protection cannot be guaranteed.
SHINGRIX est un vaccin spécialement conçu à l’intention des adultes de 50 ans ou plus pour aider leur organisme à renforcer sa protection contre le zona. Visitez notre site web pour en apprendre davantage.
